Impact BioMedical, Inc. (IBO) Operating Sales Margin

Corporate emblem and logo of Impact BioMedical (IBO)

The venture status of Impact BioMedical Inc (IBO) and the absence of stable sales create cash flow uncertainty. EBIT profitability visualizes these risks, where the -12623.70 level captures the current state. Revenues are based on the licensing of medical and digital innovations. A monetization strategy for its broad patent portfolio allows the company to avoid direct price competition within the pharmaceutical sector.

IBO - Impact BioMedical, Inc. Operating Profit Rate over the range 09/17/2024 - 11/19/2026

IBO (impactbiomedinc.com): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Fundamental company analysis:IBO, impactbiomedinc.com
Finished products of Impact BioMedical Inc

Operating margin reflects the efficiency of converting revenue into profit before taxes and interest, revealing the business's ability to generate income from core operations. By analyzing operating profitability, an investor will see Impact BioMedical Inc (IBO)'s critical dependence on external capital, as the lack of stable sales and the speculative nature of early-stage developments make this indicator extremely volatile and risky.

Analysis of competing companies

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.